Systematic and Meta-Analytic Review: Medication Adherence among Pediatric Patients with Sickle Cell Disease

Journal of Pediatric Psychology

Volumn 41, Issue 4, 2016, Pages 406-418

  Loiselle, Kristin ^a   Lee, Jennifer L ^a   Szulczewski, Lauren ^a   Drake, Sarah ^a   Crosby, Lori E ^a   Pai, Ahna L H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adherence; children; meta analysis; sickle cell disease; systematic review

Indexed keywords

ANEMIA, SICKLE CELL; CHILD; HUMAN; MEDICATION COMPLIANCE; META ANALYSIS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ANEMIA, SICKLE CELL; CHILD; HUMANS; MEDICATION ADHERENCE;

EID: 84966552380     PISSN: 01468693     EISSN: 1465735X     Source Type: Journal    
DOI: 10.1093/jpepsy/jsv084     Document Type: Review

References (79)

1. Alvarez, O., Rodriguez-Cortes, H., Robinson, N., Lewis, N., Sang, C. D. P., Lopez-Mitnik, G., Paley, C. (2009). Adherence to deferasirox in children and adolescents with sickle cell disease during 1-year of therapy. Journal of Pediatric Hematology/Oncology, 31, 739-744. doi: 10.1097/mph.0b013e3181b53363
2. Anglin, D. L., Siegel, J. D., Pacini, D. L., Smith, S. J., Adams, G., Buchanan, G. R. (1984). Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. The Journal of Pediatrics, 104, 18-22. doi: 10.1016/s0022-3476(84)80582-x
3. Aygun, B., Mortier, N. A., Smeltzer, M. P., Shulkin, B. L., Hankins, J. S., Ware, R. E. (2013). Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. American Journal of Hematology, 88, 116-119. doi: 10.1002/ajh.23365
4. Babiker, M. A. (1986a). Compliance with penicillin prophylaxis by children with impaired splenic function. Tropical and Geographical Medicine, 38, 119-122.
5. Babiker, M. A. (1986b). Prophylaxis of pneumococcal infection in sickle-cell disease. Annals of Tropical Paediatrics, 6, 179-181. Retrieved from http://ingentaconnect. com/content/0272-4936
6. Barakat, L. P., Lutz, M., Smith-Whitley, K., Ohene-Frempong, K. (2005). Is treatment adherence associated with better quality of life in children with sickle cell disease Quality of Life Research, 14, 407-414. doi: 10.1007/s11136-004-5328-0
7. Barakat, L. P., Smith-Whitley, K., Ohene-Frempong, K. (2002). Treatment adherence in children with sickle cell disease: Disease-related risk and psychosocial resistance factors. Journal of Clinical Psychology in Medical Settings, 9, 201-209. doi: 10.1023/A:1016047210623
8. Berkovitch, M., Papadouris, D., Shaw, D., Onuaha, N., Dias, C., Olivieri, N. F. (1998). Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. British Journal of Clinical Pharmacology, 45, 605-607. doi: 10.1046/j.1365-2125.1998.00730.x
9. Bitaraes, E. L., de Oliveira, B. M., Viana, M. B. (2008). Compliance with antibiotic prophylaxis in children with sickle cell anemia: A prospective study. Journal de Pediatria, 84, 316-322. doi: 10.2223/JPED.1819
10. Biostat. (2005). Comprehensive meta-analysis. Englewood, NJ: Biostat.
11. Blanchard, J., Lurie, N. (2004). R-E-S-P-E-C-T: Patient reports of disrespect in the health care setting and its impact on care. Journal of Family Practice, 53, 721-730.
12. Borenstein, M., Hedges, L. V., Higgins, J. P. T., Rothstein, H. R. (2010). A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods, 1, 97-111. doi: 10.1002/jrsm.12
13. Brawley, O. W., Cornelius, L. J., Edwards, L. R., Northington Gamble, V., Green B. L., Inturrisi, C., Schori, M. (2008). National Institutes of Health consensus development conference statement: Hydroxyurea treatment for sickle cell disease. Annals of Internal Medicine, 148, 932-938. doi: 10.7326/0003-4819-148-12-200806170-00220
14. Buchanan, G. R., Siegel, J. D., Smith, S. J., DePasse, B. M. (1982). Oral penicillin prophylaxis in children with impaired splenic function: A study of compliance. Pediatrics, 70, 926-930. doi: 10.1203/00006450-198104001-00049
15. Buchanan, G. R., Smith, S. J. (1986). Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. American Journal of Diseases of Children, 140, 428-432. doi: 10.1001/archpedi.1986.02140190038020
16. Cohen, J. A. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37-46. doi: 10.1177/001316446002000104
17. Colombatti, R., Montanaro, M., Guasti, F., Rampazzo, P., Meneghetti, G., Giordan, M., Sainati, L. (2012). Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care. Pediatric Blood and Cancer, 59, 1275-1279. doi: 10.1002/pbc.24110
18. Creary, S. E., Gladwin, M. T., Byrne, M., Hildesheim, M., Krishnamurti, L. (2014). A pilot study of directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease. Pediatric Blood and Cancer, 61, 1068-1073. doi: 10.1002/pbc.24931
19. Crosby, L. E., Barach, I., McGrady, M. E., Kalinyak, K. A., Eastin, A. R., Mitchell, M. J. (2012). Integrating interactive web-based technology to assess adherence and clinical outcomes in pediatric sickle cell disease. Anemia, 2012, 1-8. doi: 10.1155/2012/492428
20. Cummins, D., Heuschkel, R., Davies, S. C. (1991). Penicillin prophylaxis in children with sickle cell disease in Brent. British Medical Journal, 302, 989-990. doi: 10.1136/bmj.302.6783.989
21. Dalton, R. N., Turner, C., Dick, M., Height, S. E., Awogbade, M., Inusa, B., Rees, D. C. (2005). The measurement of urinary hydroxyurea in sickle cell anaemia. British Journal of Haematology, 130, 138-144. doi: 10.1111/j.1365-2141.2005.05583.x
22. Davis, H. (1998). Use of computerized health claims data to monitor compliance with antibiotic prophylaxis in sickle cell disease. Pharmacoepidemiology and Drug Safety, 7, 107-112. Retrieved from http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291099-1557
23. Day, S., Brunson, G., Wang, W. (1992). A successful education program for parents of infants with newly diagnosed sickle cell disease. Journal of Pediatric Nursing, 7, 52-58. Retrieved from http://www.pediatricnursing. org/
24. De Civita, M., Dobkin, P. L. (2004). Pediatric adherence as a multidimensional and dynamic construct, involving a triadic partnership. Journal of Pediatric Psychology, 29, 157-169. doi: 10.1093/jpepsy/jsh018
25. De Montalembert, M., Brousse, V., Elie, C., Bernaudin, F., Shi, J., Landais, P. (2006). Long-term hydroxyurea treatment in children with sickle cell disease: Tolerance and clinical outcomes. Haematologica, 91, 125-128. Retrieved from, www.haematologica.org
26. Retrieved from www.haematologica.org Dew, M. A., Dabbs, A. D., Myaskovsky, L., Shyu, S., Shellmer, D. A., DiMartini, A. F., Greenhouse, J. B. (2009).Metaanalysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation, 88, 736-746. doi: 10.1097/TP.0b013e3181b2a0e0
27. Division of Blood Diseases and Resources, National Institutes of Health National Heart, Lung, and Blood Institute. (2002). The management of sickle cell disease (NIH Publication 02-2117). Retrieved from,http://www.nhlbi.nih.gov/files/docs/guidelines/sc-mngt.pdf
28. DuRant, R. H. (1994). Checklist for the evaluation of research articles. Journal of Adolescent Health, 15, 4-8. doi: 10.1016/1054-139x(94)90381-6
29. Elliott, V., Morgan, S., Day, S., Mollerup, L. S., Wang, W. (2001). Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 23, 112-116. doi: 10.1097/00043426-200102000-00009
30. Fisak, B., Belkin, M. H., von Lehe, A. C., Bansal, M. M. (2011). The relation between health-related quality of life, treatment adherence and disease severity in a paediatric sickle cell disease sample. Child: Care, Health and Development, 38, 204-210. doi: 10.1111/j.1365-2214.2011.01223.x
31. Fowkes, F. G. R., Fulton, P. M. (1991). Critical appraisal of published research: Introductory guidelines. British Medical Journal, 302, 1136-1140. doi: 10.1136/bmj.302.6785.1136
32. Hassell, K. L. (2010). Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38, S512-S521. doi: 10.1016/j.amepre.2009.12.022
33. Hilker, K. A., Jordan, S. S., Jensen, S., Elkin, T. D., Iyer, R. (2006). Development of a screening instrument of adherence in pediatric sickle cell disease. Children's Health Care, 35, 235-246. doi: 10.1207/s15326888chc 3503-3
34. Hommel, K. A., Davis, C. M., Baldassano, R. N. (2009). Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflammatory Bowel Disease, 15, 589-593. doi: 10.1002/ibd.20798
35. Ikefuna, A. N., Emodi, I. J. (2007). Hospital admission of patients with sickle cell anaemia pattern and outcome in Enugu area of Nigeria. Nigerian Journal of Clinical Practice, 10, 24-29. Retrieved from http://www.njcponline. com/
36. Ingerski, L. M., Baldassano, R. N., Denson, L. A., Hommel, K. A. (2010). Barriers to oral medication adherence for adolescents with inflammatory bowel disease. Journal of Pediatric Psychology, 35, 683-691. doi: 10.1093/jpepsy/jsp085
37. Jensen, S. A., Elkin, T. D., Hilker, K., Jordan, S., Iyer, R., Smith, M. G. (2005). Caregiver knowledge and adherence in children with sickle cell disease: Knowing is not doing. Journal of Clinical Psychology in Medical Settings, 12, 333-337. doi: 10.1007/s10880-005-7819-8
38. Jordan, L. B., Vekeman, F., Sengupta, A., Corral, M., Guo, A., Duh, M. S. (2012). Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease. Journal of Clinical Pharmacy and Therapeutics, 37, 173-181. doi: 10.1111/j.1365-2710.2011.01276.x
39. Kauf, T. L., Coates, T. D., Huazhi, L., Mody-Patel, N., Hartzema, A. G. (2009). The cost of health care for children and adults with sickle cell disease. American Journal of Hematology, 84, 323-327. doi: 10.1002/ajh.21408
40. King, L., Ali, S., Knight-Madden, J., MooSang, M., Reid, M. (2011). Compliance with intramuscular penicillin prophylaxis in children with sickle cell disease in Jamaica. West Indian Medical Journal, 60, 177-180. Retrieved from http://caribbean.scielo.org/
41. Kinney, T. R., Helms, R. W., O'Branski, E. E., Ohene-Frempong, K., Wang, W., Daeschner, C., Ware, R. E. (1999). Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Blood, 94, 1550-1554. Retrieved from http://www.bloodjournal. org/
42. Landis, J. R., Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrika, 33, 159-174. doi: 10.2307/2529310
43. MacDonell, K., Naar-King, S., Huszti, H., Belzer, M. (2013). Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS and Behavior, 17, 86-93. doi: 10.1007/s10461-012-0364-1
44. McGrady, M. E., Hommel, K. A. (2013). Medication adherence and health care utilization in pediatric chronic illness: A systematic review. Pediatrics, 132, 730-740. doi: 10.1542/peds.2013-1451
45. Modi, A. C., Pai, A. L., Hommel, K. A., Hood, K. K., Cortina, S., Hilliard, M. E., Drotar, D. (2012). Pediatric selfmanagement: A framework for research, practice, and policy. Pediatrics, 129, e473-e485. doi: 10.1542/peds.2011-1635
46. Morisky, D. E., Green, L. W., Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24. 67-74.
47. Musa, D., Schilz, R., Harris, R., Silverman, M., Thomas, S. B. (2009). Trust in the health care system and the use of preventive health services by older Black and White adults. American Journal of Public Health, 99, 1293-1299. doi: 10.2105/AJPH.2007.123927
48. Nottage, K. A., Hankins, J. S., Smeltzer, M., Mzayek, F., Wang, W. C., Aygun, B., Gurney, J. G. (2013). Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PLoS ONE, 8, e72077. doi: 10.1371/journal.pone.0072077
49. Olivieri, N. F., Vichinksy, E. P. (1998). Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy. Journal of Pediatric Hematology/Oncology, 20, 26-31. doi: 10.1097/00043426-199801000-00004
50. Patel, A. B., Athavale, A. M. (2004). Sickle cell disease in central India. Indian Journal of Pediatrics, 71, 789-793. doi: 10.1007/bf02730713
51. Patel, N. G., Lindsey, T., Strunk, R. C., DeBaun, M. R. (2010). Prevalence of daily medication adherence among children with sickle cell disease: A one-year retrospective cohort analysis. Pediatric Blood and Cancer, 55, 554-556. doi: 10.1002/pbc.22605
52. Pejaver, R. K., Ahmed, F. E., Al Hifzi, I. (1997). Compliance to penicillin prophylaxis amongst Saudi children. Journal of the Irish Colleges of Physicians and Surgeons, 26, 268-270.
53. Quittner, A. L., Espelage, D. L., Ievers-Landis, C., Drotar, D. (2000). Measuring adherence to medical treatments in childhood chronic illness: Considering multiple methods and sources of information. Journal of Clinical Psychology in Medical Settings, 7, 41-54. doi: 10.1023/A:1009545319673
54. Raphael, J. L., Butler, A. M., Rattler, T. L., Kowalkowski, M. A., Mueller, B. U., Giordano T. P. (2013). Parental information, motivation, and adherence behaviors among children with sickle cell disease. Pediatric Blood and Cancer, 60, 1204-1210. doi: 10.1002/pbc.24466
55. Rapoff, M. A. (2010). Adherence to pediatric medical regimens (2nd ed.). New York, NY: Springer.
56. Rees, D. C., Williams, T. N., Gladwin, M. T. (2010). Sickle-cell disease. The Lancet, 376, 2018-2031. doi: 10.1016/S0140-6736(10)61029-X
57. Resar, L. M. S., Segal, J. B., Fitzpatric, L. K., Friedmann, A., Brusilow, S. W., Dover, G. J. (2002). Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy. Journal of Pediatric Hematology/Oncology, 24, 737-741. doi: 10.1097/00043426-200212000-00011
58. Sabin, J. A., Rivara, F. P., Greenwald, A. G. (2008). Physician implicit attitudes and stereotypes about race and quality of medical care. Medical Care, 46, 678-685. doi: 10.1097/MLR.0b013e3181653d58
59. Scott, J. P., Hillery, C. A., Brown, E. R., Misiewicz, V., Labotka, R. J. (1996). Hydroxyurea therapy in children severely affected with sickle cell disease. The Journal of Pediatrics, 128, 820-828. doi: 10.1016/s0022-3476(96)70335-9
60. Simons, L. E., McCormick, M. L., Devine, K., Blount, R. L. (2010). Medication barriers predict adolescent transplant recipients' adherence and clinical outcomes at 18-month follow-up. Journal of Pediatric Psychology, 35, 1038-1048. doi: 10.1093/jpepsy/jsq025
61. Smith, L. A., Oyeku, S. O., Homer, C., Zuckerman, B. (2006). Sickle cell disease: A question of equity and quality. Pediatrics, 117, 1763-1770. doi: 10.1542/peds.2005-1611
62. Sox, C. M., Cooper, W. O., Koepsell, T. D., DiGiuseppe, D. L., Christakis, D. A. (2003). Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA, 290, 1057-1061. doi: 10.1001/jama.290.8.1057
63. Teach, S. J., Lillis, K. A., Grossi, M. (1998). Compliance with penicillin prophylaxis in patients with sickle cell disease. Archives of Pediatric Medicine, 152, 274-278. doi: 10.1001/archpedi.152.3.274
64. Thornburg, C. D., Calatroni, A., Telen, M., Kemper, A. R. (2010). Adherence to hydroxyurea therapy in children with sickle cell anemia. Journal of Pediatrics, 156, 415-419. doi: 10.1016/j.peds.2009.09.044
65. Thornburg, C. D., Rogers, Z. R., Jeng, M. R., Rana, S. R., Iyer, R. V., Faughnan, L., Rees, R. C. (2010). Adherence to study medication and visits: Data from the BABY HUG trial. Pediatric Blood and Cancer, 54, 260-264. doi: 10.1002/pbc.22324
66. Treadwell, M. J., Law, A.W., Sung, J., Hackney-Stephens, E., Quirolo, K.,Murray, E., Vichinsky, E. (2005). Barriers to adherence to deferoxamine usage in sickle cell disease. Pediatric Blood and Cancer, 44, 500-507. doi: 10.1002/pbc.20290
67. Tsouana, E., Kaya, B., Gadong, N., Hemmaway, C., Newell, H., Simmons, A., Telfer, P. (2015). Deferasirox for iron chelation inmultitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network. European Journal of Haematology. 94, 336-342. doi: 10.1111/ejh.12345
68. Van Sciver, M. M., D'Angelo, E. J., Rappaport, L., Woolf, A. D. (1995). Pediatric compliance and the roles of distinct treatment characteristics, treatment attitudes, and family stress: A preliminary report. Journal of Developmental and Behavioral Pediatrics, 16, 350-358. doi: 0196-206X/95/1605-0350$03.00/0
69. Walsh, K. E., Cutrona, S. L., Kavanah, P. L., Crosby, L. E., Malone, C., Lobner, K., Bundy, D. G. (2014). Medication adherence among pediatric patients with sickle cell disease: A systematic review. Pediatrics, 134, 1175-1183. doi: 10.1542/peds.2014-0177
70. Ware, R. E., Eggleston, B., Redding-Lallinger, R., Wang, W. C., Smith-Whitley, K., Daeschner, C., Ohene-Frempong, K. (2002). Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood, 99, 10-14. doi: 10.1182/blood.V99.1.10
71. Ware, R. E., Zimmerman, S. A., Schultz, W. H. (1999). Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood, 94, 3022-3026. Retrieved from http://www.bloodjournal.org/
72. Ware, R. E., Zimmerman, S. A., Sylvestre, P. B., Mortier, N. A., Davis, J. S., Treem, W. R., Schultz, W. H. (2004). Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. Journal of Pediatrics, 145, 346-352. doi: 10.1016/j.peds.2001.04.058.
73. Warren, M. D., Arbogast, P. G., Dudley, J. A., Kaltenbach, L., Ray, W. A., Wang, W. C., Cooper, W. O. (2010). Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease. Archives of Pediatric and Adolescent Medicine, 164, 298-299. doi: 10.1001/archpediatrics.2009.286
74. Williams, L. L., Wilimas, J. A., Harris, S. C., Day, S. W., Dancy, R. M., Wang, W. C. (1996). Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 18, 257-261. doi: 10.1097/00043426-199608000-00004
75. Williams, R., Olivi, S., Chin-Shang, L., Storm, M., Cremer, L., Mackert, P., Wang, W. (2004). Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 26, 619-625. doi: 10.1097/01.mph.0000140651. 65591.b8
76. Witherspoon, D., Drotar, D. (2006). Correlates of adherence to prophylactic penicillin therapy in children with sickle cell disease. Children's Health Care, 35, 281-296. doi: 10.1207/s15326888chc3504-1
77. Wojciechowski, E. A., Hurtig, A., Dorn, L. (2002). A natural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: A need for case management services. Journal of Pediatric Nursing, 17, 18-27. doi: 10.1053/jpdn.2002.30930
78. Zimmerman, S. A., Schultz, W. H., Burgett, S., Mortier, N. A., Ware, R. E. (2007). Hydroxyurea therapy lowers transcranial doppler flow velocities in children with sickle cell anemia. Blood, 11, 1043-1047. doi: 10.1182/blood-2006-11-057893
79. Zimmerman, S. A., Schultz, W. H., Davis, J. S., Pickens, C. V., Mortier, N. A., Howard, T. A., Ware, R. E. (2004). Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood, 103, 2039-2045. doi: 10.1182/blood-2003-07-2475